Cabe after the successful completion of phase i would expect a market cap of at least 50 million which would give a sp of some 5 cents.This price would really show no moving forward value.
After commercialisation, well we know that many would possibly switch from the inferior Somavert so the following passage in the presentation comes in to play.Potentially a market cap in this instant for ANP of who knows as the future potential needs to be taken into account but i would expect to see ANP in this scenario trading near 70 cents minimum in my view.
"Target market for ATL1103 is at least the 35-40% of acromegalics who are not controlled on somatostatiins,in addition to those who would switch from Somavert?
because of therapy limitations = potential market opportunity of up to $500 mill/annum in acromegaly indication."
Robbbssstttarrrrrr
- Forums
- ASX - By Stock
- PER
- anything over 25mil
anything over 25mil, page-12
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CXO
Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
HCH
Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
-0.002(2.41%) |
Mkt cap ! $73.02M |
Open | High | Low | Value | Volume |
8.1¢ | 8.2¢ | 8.0¢ | $39.27K | 485.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 365000 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 57142 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 365000 | 0.082 |
2 | 37265 | 0.081 |
3 | 88252 | 0.080 |
2 | 212658 | 0.078 |
1 | 108571 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 57142 | 1 |
0.085 | 90800 | 2 |
0.086 | 106100 | 2 |
0.087 | 158719 | 2 |
0.088 | 166793 | 7 |
Last trade - 14.51pm 11/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |